Axillary MRI Is No Better than a Clinical Exam Alone in Predicting Breast Cancer in Sentinel Nodes after Neoadjuvant Chemotherapy
Magnetic resonance imaging (MRI) of the axilla after neoadjuvant chemotherapy is no more accurate than a clinical exam alone in predicting sentinel lymph node pathology in breast cancer patients with clinical N1 disease.